Frazier Healthcare Partners

Frazier Healthcare Partners is a private equity and venture capital firm founded in 1991 and headquartered in Seattle, Washington, with additional offices in New York and Menlo Park. Exclusively focused on healthcare, the firm has raised over $11 billion in total capital across more than 11 dedicated funds and has invested in over 200 companies across the US, Canada, and Europe. The firm operates through two distinct investment teams: the Growth Buyout team, which targets profitable lower middle-market healthcare companies with $5–50 million in EBITDA, making equity commitments of $30–350 million via buyouts, recapitalizations, and corporate carveouts; and the Life Sciences team, which invests in and forms early-stage biotech and therapeutics companies addressing unmet medical needs. A hallmark of the Growth Buyout approach is its Executive in Residence program, which pairs proven healthcare executives with curated investment theses, with those executives typically stepping into CEO or Executive Chairman roles at portfolio companies. The firm's sector focus spans healthcare services, pharmaceutical services, medical products, and life sciences. Current and recent portfolio companies include AirLife, CSafe, Matrix Medical Network, RevSpring, Vatica Health, Caravel Autism Health, EPTAM Precision, Adare Pharma Services, United Digestive, Leiters, Solis Mammography, and CHG Healthcare, among many others.